Family Medicine Doctors in Oak Point, TX Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Paul W Wright, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 Oak View Dr, Oak Point, TX 75068 Phone: 214-407-6350 |
Derek A Farley, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 931 Topaz Ln, Oak Point, TX 75068 Phone: 972-292-3911 Fax: 972-292-3911 |
David Crockett Harper, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1001 Fox Hollow Ln, Oak Point, TX 75068 Phone: 972-294-0205 |
News Archive
HOXB7 gene raises tamoxifen resistance in women with early-stage breast cancer
A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.
CI Index of cancer immunotherapy stocks increases 80% during quarter; two companies lead CI index
The Cancer Immunotherapy Index of ten leading cancer immunotherapy stocks has increased 80% during its first three months of measurement. The CI Index as a whole trades for 10% of estimated future revenues.
WSU study could help predict mild cognitive impairment, Alzheimer's disease
Mild cognitive impairment, or MCI, may be one of Alzheimer's earliest signs. The subtle changes of MCI include problems with memory, language, thinking and judgment and a subjective sense that mental function is getting worse.
Obama lunches with Senate GOP, focuses on entitlement programs
A key message from Republican lawmakers was that President Barack Obama should tone down his rhetoric on changes to Medicare.
Merck, PDS Biotechnology enter licensing agreement for Versamune
PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.
› Verified 4 days ago